Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
A novel role for gangliosides in extracellular vesicle biogenesis and mHTT secretion
FY 2021-22
Summary
Huntington's disease (HD) is a genetic disorder caused by a mutation in the Huntingtin gene that results in the formation and accumulation of the toxic mutant Huntingtin protein (mHTT). Abundance of mHTT causes accretion of neuronal death in the brain, inducing a triad of cognitive, motor, and psychiatric symptoms. In addition, studies in experimental models of Huntington's have shown a decrease in key fat molecules known as gangliosides. Gangliosides are normally abundant in the brain where they play important roles in cell-cell communication. In our laboratory, we have demonstrated the therapeutic effects of administration of the ganglioside GM1 in HD cell and animal models, which are associated with a decrease in mHTT in the brain of HD mice. Preliminary data suggests that this might be due to the ability of gangliosides to induce the production and cellular secretion of particles known as extracellular vesicles (EVs) carrying mHTT and other harmful toxic proteins outside of cells. Through my studies, I aim to identify the mechanism by which GM1 increases EV production and promotes the packaging of mHTT into EVs. I will test the hypothesis that an increased presence of GM1 in cell membranes, enhances the abundance and activity of proteins involved in EV production. My studies will elucidate the mechanism underlying GM1s therapeutic effects and may accelerate the development of ganglioside-based therapies for HD.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466524
Name
Ibanga Jeremies U
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A novel role for gangliosides in extracellular vesicle biogenesis and mHTT secretion
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Extracellular Vesicles; Gangliosides; Huntington'S Disease; Neurodegeneration; Neuroprotection; Proteastasis
Abstract
Huntington's disease (HD) is a genetic disorder caused by a mutation in the Huntingtin gene that results in the formation and accumulation of the toxic mutant Huntingtin protein (mHTT). Abundance of mHTT causes accretion of neuronal death in the brain, inducing a triad of cognitive, motor, and psychiatric symptoms. In addition, studies in experimental models of Huntington's have shown a decrease in key fat molecules known as gangliosides. Gangliosides are normally abundant in the brain where they play important roles in cell-cell communication. In our laboratory, we have demonstrated the therapeutic effects of administration of the ganglioside GM1 in HD cell and animal models, which are associated with a decrease in mHTT in the brain of HD mice. Preliminary data suggests that this might be due to the ability of gangliosides to induce the production and cellular secretion of particles known as extracellular vesicles (EVs) carrying mHTT and other harmful toxic proteins outside of cells. Through my studies, I aim to identify the mechanism by which GM1 increases EV production and promotes the packaging of mHTT into EVs. I will test the hypothesis that an increased presence of GM1 in cell membranes, enhances the abundance and activity of proteins involved in EV production. My studies will elucidate the mechanism underlying GM1s therapeutic effects and may accelerate the development of ganglioside-based therapies for HD.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ibanga, Jeremies U
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~